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Abstract
Background: Simian virus 40 (SV40) enters cells via an atypical caveolae-mediated endocytic
pathway, which delivers the virus to a new intermediary compartment, the caveosome. The virus
then is believed to go directly from the caveosome to the endoplasmic reticulum. Cholera toxin
likewise enters via caveolae and traffics to caveosomes. But, in contrast to SV40, cholera toxin is
transported from caveosomes to the endoplasmic reticulum via the Golgi. For that reason, and
because the caveosome and Golgi may have some common markers, we revisited the issue of
whether SV40 might access the endoplasmic reticulum via the Golgi.
Results: We confirmed our earlier finding that SV40 co localizes with the Golgi marker β -COP.
However, we show that the virus does not co localize with the more discriminating Golgi markers,
golgin 97 and BODIPY-ceramide.
Conclusion: The caveolae-mediated SV40 entry pathway does not intersect the Golgi. SV40 is
seen to co localize with β -COP because that protein is a marker for caveosomes as well as the
Golgi. Moreover, these results are consistent with the likelihood that the caveosome is a sorting
organelle. In addition, there are at least two distinct but related routes by which a ligand might
traffic from the caveosome to the ER; one route involving transport through the Golgi, and another
pathway that does not involve the Golgi.
Background
Viruses commonly enter cells by receptor-mediated endo-
cytosis; an entry pathway involving clathrin-coated pits
and vesicles derived from them. These vesicles generally
transport the virus to the endosomal/lysosomal compart-
ment, where acidic conditions trigger virus disassembly
and genome release [1].
Earlier experimental findings demonstrated that the entry
pathway for simian virus 40 (SV40) might differ in impor-
tant ways from the more common virus entry pathway.
First, SV40 infection was found to be independent of the
low pH of the endosomal/lysosomal compartment [2].
Second, electron microscopy studies showed that entering
SV40 traffics to the endoplasmic reticulum (ER), rather
than to endosomes [3]. More recently, SV40 was shown to
enter cells via caveolae, rather than clathrin-coated pits
[4,5]. Indeed, these were the first reports of a virus enter-
ing cells by means of caveolae. In addition, SV40 entry is
signal-dependent, in contrast to the constitutive endocy-
tosis of viruses that enter via clathrin-coated pits [6-8].
Finally, SV40 particles disassemble in the ER, rather than
in the endosomal/lysosomal compartment [9].
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Caveolae are small (70 to 100 nm) invaginations of the
plasma membrane that are distinguished from clathrin-
coated pits by their size, distinctive flask-like shape, and
lack of a visible coat in thin sections. Expression of the
protein caveolin-1 triggers the formation of caveolae in
microdomains of the plasma membrane that are enriched
in sphingolipids and cholesterol, and which are known as
lipid rafts [10,11]. The cellular functions of caveolae are
not yet entirely clear, but they have been implicated in
organizing signal transduction pathways, and in sorting
and trafficking through the endocytic and secretory path-
ways [12-14].
The endocytic trafficking of any ligand from the plasma
membrane to the ER is most exceptional. Thus, it was
important to ascertain the pathway taken by SV40. Chol-
era toxin (CT) provided a precedent for a possible SV40
entry pathway since it earlier had been shown to enter
cells via caveolae, and also to traffic to the ER [15].
Interestingly, CT also can enter cells via clathrin-coated
pits. Yet pharmacologically impairing the clathrin-medi-
ated entry pathway had little effect on the toxic effects of
CT. In contrast, selective inhibition of caveolae-mediated
uptake prevented CT toxicity [15]. Importantly, produc-
tive SV40 infection likewise was prevented by pharmaco-
logically impairing caveolae-mediated endocytosis, but
not by blocking clathrin-mediated entry [4]. These exper-
imental findings demonstrated that a caveolae-mediated
entry pathway, rather than a clathrin-mediated pathway,
is the physiologically relevant one for both the toxin and
SV40. Moreover, these results also imply that the clathrin-
coated pit-mediated pathway and the caveolae-mediated
pathway do not mix or intersect at any point.
Importantly, CT traffics through the Golgi en route to the
ER [16]. Transport of the toxin from the Golgi to the ER is
mediated by the Golgi-to-ER retrieval pathway, which
normally retrieves resident ER proteins that have escaped
to the Golgi with the anterograde flux. In contrast, rather
than trafficking to the Golgi, SV40 was seen to traffic to a
new organelle, the caveosome. SV40 is then transported
directly from the caveosome to the ER [17].
Little is known about caveosomes. They contain caveolin-
1, but are non-acidic, and they do not contain markers for
endosomes, lysosomes, or the ER. Importantly, caveo-
somes also do not contain the Golgi markers TGN46 or
mannosidase II, implying that they are distinct from the
Golgi [17].
Prior to the report that SV40 traffics to the ER via caveo-
somes [17], we set out to ask whether SV40, like CT, might
traffic to the ER via the Golgi. We selected β -COP as our
Golgi marker since this protein is best known as a compo-
nent of the COPI coatamer complexes that mediate the
retrograde retrieval pathway from the Golgi to the ER [18-
21]. We found that SV40 indeed co localizes with β -COP
before it enters the ER. However, in light of the report that
SV40 traffics through caveosomes, rather than through the
Golgi [17], we interpreted our findings and redirected our
subsequent experiments as follows.
First, note that the recycling pathway from the Golgi to the
ER is mediated by COPI coatamers that assemble on Golgi
membranes [22-24]. Thus, since SV40, like CT, is trans-
ported from an intermediate compartment to the ER
(from caveosomes in the case of SV40, and from the Golgi
in the case of CT), we hypothesized that the SV40 pathway
from caveosomes to the ER likewise might be mediated by
COPI coatamers. This premise accounts both for the co
localization of SV40 with β -COP [9], and the targeting of
the virus to the ER.
Considering the above, we asked whether β -COP indeed
might be present on caveosomes, and whether it might
mediate trafficking from caveosomes to the ER. First, we
demonstrated that β -COP in fact does co localize with
caveolin-1 on an organelle that contains input SV40. Sec-
ond, the simultaneous co localization of SV40 with both
β -COP and caveolin-1 is seen before the virus appears in
the ER [9]. Thus, the β -COP-containing intermediate
organelle appears to be the caveosome [17]. Third, we and
others reported that transport of SV40 from the interme-
diate organelle to the ER is blocked by the drug brefeldin
A, which specifically inhibits the Ras-like GTPase ARF-1
that regulates assembly of COPI coat complexes [9,25].
Note that CT transport to the ER likewise is blocked by
brefeldin A, as well as by microinjected antibodies against
β -COP [23,26,27]. These experimental results confirm
that SV40 indeed traffics through a caveolin-1-containing
compartment, which most likely is the caveosome, en
route to the ER. Moreover, they demonstrate that the cave-
osome, like the Golgi, is marked by β -COP. Finally, the
pathway from the caveosome to the ER, like the retrograde
pathway from the Golgi to the ER, is dependent on assem-
bly of COPI coat complexes [9].
Now, for several reasons, we believe that it is important to
revisit the question of whether SV40 is transported to the
ER via the Golgi. Most importantly, there is the precedent
provided by CT for a caveolae-mediated endocytic path-
way that accesses the ER via the Golgi. This precedent
becomes more compelling in view of the more recent dis-
covery that CT traffics through a caveolin-1-containing
"endosomal" compartment on its path to the Golgi [16].
Moreover, that compartment may well be identical to
caveosomes, as demonstrated by the finding that when
cells are allowed to simultaneously endocytose CT and
SV40, these ligands are observed to co localize in caveolin-Virology Journal 2005, 2:38 http://www.virologyj.com/content/2/1/38
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1-positive endosomes [16]. Yet CT then traffics to the
Golgi en route to the ER, whereas SV40 is said to traffic
directly from caveosomes to the ER. Finally, in most cul-
tured cells caveolin-1 is seen in the Golgi, as well as at the
cell surface.
In the current study, we sought to confirm our earlier find-
ing that SV40 co localizes with β -COP [9]. In addition, we
ask whether SV40 co localizes with two standard Golgi
markers: golgin 97 and BODIPY-ceramide.
Results and Discussion
In agreement with our earlier report [9], SV40 indeed co
localized with β -COP at all three time points examined (3,
5, and 10 hours), although co localization was dimin-
ished by 10 hours (Figure 1A, B, and 1C, 3-hour sample
shown). Regarding the latter observation, we demon-
strated earlier that SV40 appears in the ER between five
and ten hours, and most of the virus is in the ER by 10
hours [9].
In contrast to the early co localization of SV40 with β -
COP, at no time was SV40 seen to co localize with Golgi
markers golgin 97 (Figure 1D, E, and 1F, 5-hour sample
shown) and BODIPY-ceramide (Figure 1G, H, and 1I, 3
hour sample shown).
The golgins in general are Golgi-localized proteins, char-
acterized by an extensive coiled-coil structure throughout
the entire molecule. The anti-human golgin 97 mono-
clonal antibodies used here recognize a 97 kD protein
called golgin 97, a peripheral membrane protein that
appears to be localized exclusively on the cytoplasmic face
of the Golgi [28]. The exact function of golgin 97 is not
known, although there is evidence that it may act to regu-
late transport between endosomes and the Golgi [29]. Flu-
orescent ceramide analogs, such as BODIPY-ceramide, are
used extensively as selective stains for the Golgi [e.g.,
[30]]. They accumulate in this organelle, presumably
because of its role in lipid biosynthesis and trafficking.
Indeed β -COP also is used as a Golgi marker. It preferen-
tially associates with the lateral rims of the cis and medial
Golgi cisternae, and the buds and vesicles derived from
them. However, β -COP is not entirely specific to the Golgi
since it also is associated with endosomal vesicles scat-
tered throughout the cytoplasm [31,32]. Our own recent
experimental results strongly implied that β -COP also is
associated with caveolin-1-containing caveosomes [9].
Based upon the differential co localization of SV40 with β -
COP, but not with the less promiscuous Golgi markers,
golgin 97 and BODIPY-ceramide, we conclude that SV40
does not traffic through the Golgi en route to the ER.
Both SV40 and CT traffic from the plasma membrane to a
common intermediate compartment, which appears to be
the caveosome [16]. Since SV40 then traffics directly to
the ER, whereas CT is first transported to the Golgi, the
caveosome compartment would seem to have the ability
to sort its different cargos for transport to different desti-
nations. How this sorting might be achieved remains to be
discovered. Caveolin-1 is not likely to play a role in this
differential sorting of SV40 and CT, since that protein
does not traffic with either ligand to its next destination
[16,17]. Moreover, in cells lacking caveolin-1 expression
and, therefore, caveolae, SV40 enters via lipid rafts, and
still traffics to the ER via neutral organelles that resemble
caveosomes, except that they do not contain caveolin-1
[33].
Understanding the determinants of these atypical traffick-
ing pathways is fundamentally important since virtually
all host ligands that are not internalized via clathrin-
coated pits (e.g., sphingolipids, GPI-linked proteins) enter
via sphingolipid and cholesterol-enriched membrane
domains, and at least some traffic to a caveosome-like
compartment, from which they then are sorted. This clath-
rin-independent mode of endocytosis likely enables these
ligands to access sites that can not be accessed from the
clathrin-dependent endocytic pathway.
SV40 binds to major histocompatibility complex (MHC)
class I molecules at the cell surface [34,35]. However,
MHC class I molecules do not internalize with the virus
[36]. An interaction of SV40 with the ganglioside GM1 at
the plasma membrane recently was shown to greatly
enhance infectivity of the virus [37]. Perhaps SV40 uses
GM1 as a co-receptor to deliver the virus into the cell.
Interestingly, several bacterial toxins likewise use ganglio-
sides for their cell surface receptors. In particular, CT binds
to GM1 via its B subunit, and that interaction is necessary
for the retrograde transport of CT via the Golgi to the ER
[38]. It will be interesting to identify the factors which
determine that SV40 takes a direct route from the caveo-
some to the ER.
Conclusion
SV40 does not traffic through the Golgi en route from the
cell surface to the ER. Based upon the current report and
the earlier work of others regarding SV40 and cholera
toxin [16], the caveosome appears to be an organelle able
to sort its different cargos for transport to different desti-
nations within the cell. Moreover, there are at least two
distinct but related routes by which a ligand might traffic
from the plasma membrane to the endoplasmic reticu-
lum; one involving transport through the Golgi, and the
other not involving the Golgi.Virology Journal 2005, 2:38 http://www.virologyj.com/content/2/1/38
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Methods
Cell cultures and infections
CV-1 cells (from the American Type Culture Collection)
were seeded on 8 well Lab-Tek chamber slides (Nalge
Nunc). SV40 was adsorbed to cells for 1 h at 4°C, at a mul-
tiplicity of infection of 50 to 100 plaque-forming units per
cell. Cultures then were incubated at 37°C in Dulbecco
modified Eagle medium plus 10% newborn calf serum
SV40 co localizes with β -COP (A, B, C, 3-hour sample), but not with the more stringent Golgi markers, golgin 97 (D, E, F, 5- hour sample) and BODIPY-ceramide (G, H, I, 3-hour sample) Figure 1
SV40 co localizes with β -COP (A, B, C, 3-hour sample), but not with the more stringent Golgi markers, golgin 97 (D, E, F, 5-
hour sample) and BODIPY-ceramide (G, H, I, 3-hour sample).Virology Journal 2005, 2:38 http://www.virologyj.com/content/2/1/38
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(Atlanta Biologicals). At 3, 5, and 10 hours post infection,
samples were washed five times in phosphate-buffered
saline and fixed with 70% methanol at -20°C for 10 min.
Confocal immunofluorescence microscopy
Confocal immunofluorescence microscopy was carried
out using an epifluorescence Nikon E600light micro-
scope. An ORCA-ER-cooled CCD camera (Hamamatsu)
and OPENLAB software (Improvision) were used for all
image acquisition and processing. Primary antibodies
were monoclonal anti-β -COP antisera (Sigma), mono-
clonal anti-golgin 97 antisera (Molecular Probes), and our
rabbit anti-SV40 antisera [9]. BODIPY (TR)-ceramide was
from Molecular Probes. Secondary antibodies were fluo-
rescein-conjugated goat anti-rabbit immunoglobulin G
(IgG), Texas Red (TR)-conjugated goat anti-rabbit IgG,
fluorescein-conjugated donkey anti-mouse IgG, and TR-
conjugated donkey anti-mouse IgG (Jackson Laboratories,
West Grove, PA). All antisera were diluted 1:100.
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